Acquired Sales Corp. (AQSP) — AI-Aktienanalyse

Acquired Sales Corp. is currently exploring acquisitions in the cannabidiol (CBD) sector, transitioning from its previous focus on software and hardware. The company aims to capitalize on the growing market for CBD-infused products.

Unternehmensueberblick

Kurzfassung:

Acquired Sales Corp. (AQSP) is a holding company transitioning to the CBD market, exploring acquisitions of businesses involved in manufacturing and selling CBD-infused products. Previously focused on software, AQSP seeks to leverage the growing demand for CBD products within the consumer defensive sector.

Ueber AQSP

Founded in 1986 and headquartered in Lake Forest, Illinois, Acquired Sales Corp. (AQSP) initially operated in the software and hardware sectors, providing licenses, hardware, consulting, and maintenance services. Recognizing the evolving market landscape, AQSP has shifted its strategic focus towards the burgeoning cannabidiol (CBD) industry. Currently, the company does not have significant ongoing operations from its previous business model. AQSP is actively exploring potential acquisitions of operating businesses that manufacture and sell CBD-infused products. These products encompass a wide range, including beverages, muscle/joint rubs, oils, crystals, tinctures, bath bombs, isolate, relief balms, elixirs, body washes, med sticks, lotions, vape pens and cartridges, shatter, and gummies. This strategic pivot aims to capitalize on the increasing consumer demand for CBD products and establish a foothold in a rapidly expanding market. The company's future success hinges on its ability to identify and integrate suitable acquisition targets within the competitive CBD landscape.

Investmentthese

Acquired Sales Corp.'s investment thesis hinges on its successful transition into the CBD market through strategic acquisitions. The company's ability to identify and integrate profitable CBD businesses is crucial, given its current lack of significant operations. Key value drivers include the growth rate of the CBD market, which is projected to expand significantly over the next few years. Successful acquisitions could lead to substantial revenue growth and improved profitability. However, the company faces risks associated with regulatory uncertainty in the CBD industry and intense competition. The negative P/E ratio of -33.87 and a negative profit margin of -2.7% highlight the company's current financial challenges. The company's beta of -1.60 suggests it is less volatile than the market. The gross margin of 34.0% indicates potential for profitability if operations are scaled effectively.

Branchenkontext

Acquired Sales Corp. operates within the consumer defensive sector, specifically targeting the household and personal products industry through its planned entry into the CBD market. The CBD market is experiencing rapid growth, driven by increasing consumer awareness and acceptance of CBD products for various health and wellness applications. However, the industry is also characterized by intense competition and evolving regulatory landscapes. Companies like AIXN, EWOOF, HOJI, IDBHF, and LRKKF represent some of the competitors in the broader market. AQSP's success will depend on its ability to differentiate itself through product innovation, effective marketing, and strategic partnerships.

Household & Personal Products

Consumer Defensive

Wachstumschancen

Expansion into New CBD Product Categories: AQSP can explore opportunities to expand its product offerings within the CBD market. This includes developing new formulations, delivery methods, and product categories to cater to diverse consumer preferences. The global CBD market is projected to reach billions of dollars in the coming years, offering significant growth potential for companies that can innovate and capture market share. Timeline: Ongoing.
Strategic Partnerships and Distribution Agreements: AQSP can pursue strategic partnerships with established retailers, distributors, and e-commerce platforms to expand its reach and market penetration. Collaborating with established players can provide access to existing customer bases and distribution networks, accelerating revenue growth. The market for CBD products is increasingly competitive, making strategic partnerships essential for success. Timeline: Ongoing.
Geographic Expansion: AQSP can explore opportunities to expand its operations into new geographic markets, both domestically and internationally. The demand for CBD products is growing globally, presenting opportunities to establish a presence in underserved markets. However, navigating regulatory differences across jurisdictions is crucial for successful geographic expansion. Timeline: 1-3 years.
Development of Proprietary CBD Formulations: Investing in research and development to create proprietary CBD formulations with enhanced efficacy and bioavailability can provide a competitive advantage. Differentiated products with unique benefits can command premium pricing and attract a loyal customer base. The market for innovative CBD products is expected to grow rapidly as consumers seek more effective solutions. Timeline: 2-5 years.
Acquisition of Complementary Businesses: AQSP can pursue acquisitions of complementary businesses within the CBD value chain, such as extraction facilities, testing laboratories, and marketing agencies. This can create synergies and enhance the company's overall capabilities. The consolidation of the CBD industry is expected to continue, presenting opportunities for strategic acquisitions. Timeline: Ongoing.

Negative P/E ratio of -33.87 reflects current lack of profitability as the company transitions its business model.
Gross margin of 34.0% suggests potential for profitability in the CBD sector if acquisitions are successful.
Beta of -1.60 indicates lower volatility compared to the overall market.
Profit Margin of -2.7% reflects ongoing operational losses as the company explores new acquisitions.
No dividend yield reflects the company's current focus on reinvesting capital into strategic acquisitions.

Was das Unternehmen tut

Currently exploring acquisitions in the CBD-infused products market.
Previously engaged in selling software licenses and hardware.
Offered consulting and maintenance services for software and hardware.
Aims to manufacture and sell CBD products like beverages and topicals.
Seeking to capitalize on the growing demand for CBD products.
Transitioning from a technology-focused business to a consumer-focused CBD business.

Geschaeftsmodell

Acquisition-based growth strategy focused on CBD companies.
Manufacturing and distribution of CBD-infused products.
Potential for online and retail sales channels.
Revenue generation through product sales.

Consumers seeking CBD-infused products for health and wellness.
Retailers and distributors of CBD products.
Potential partnerships with health and wellness providers.
Online shoppers interested in CBD products.

First-mover advantage in acquiring promising CBD businesses (if successful).
Potential for brand recognition in the CBD market.
Proprietary CBD formulations (if developed).
Established distribution network (if acquired).

Katalysatoren

Upcoming: Potential acquisitions of CBD businesses could drive revenue growth.
Ongoing: Increasing consumer demand for CBD products.
Ongoing: Regulatory developments in the CBD industry could create new opportunities.

Risiken

Potential: Intense competition in the CBD market could limit market share.
Potential: Evolving regulatory landscape for CBD products creates uncertainty.
Ongoing: Dependence on successful acquisitions to execute business strategy.
Ongoing: Negative P/E ratio and profit margin reflect current financial challenges.
Potential: Fluctuations in raw material prices (hemp, CBD isolate).

Staerken

Strategic shift towards the growing CBD market.
Potential for first-mover advantage in acquiring promising CBD businesses.
Experienced management team (if applicable to acquired businesses).
Established infrastructure (if applicable to acquired businesses).

Schwaechen

Lack of significant current operations.
Dependence on successful acquisitions.
Limited brand recognition in the CBD market.
Negative P/E ratio and profit margin.

Chancen

Expansion into new CBD product categories.
Strategic partnerships and distribution agreements.
Geographic expansion into new markets.
Development of proprietary CBD formulations.

Risiken

Intense competition in the CBD market.
Evolving regulatory landscape for CBD products.
Potential for negative consumer perception of CBD.
Fluctuations in raw material prices (hemp, CBD isolate).

Wettbewerber & Vergleichsunternehmen

AIXN Group Inc. — Focuses on CBD and hemp-based products. — (AIXN)
Elixinol Wellness Limited — Global CBD brand with diverse product range. — (EWOOF)
Hemp Inc. — Diversified hemp company with various applications. — (HOJI)
Isodiol International Inc — CBD product manufacturer and distributor. — (IDBHF)
Love Hemp Group PLC — UK-based CBD brand with focus on quality and innovation. — (LRKKF)

Key Metrics

Volume: 0
MoonshotScore: 59/100

Company Profile

CEO: Gerard M. Jacobs
Headquarters: Lake Forest, US
Employees: 70
Founded: 2018

AI Insight

AI analysis pending for AQSP

OTC Tier: OTC Other
Disclosure Status: Unknown

Fragen & Antworten

What does Acquired Sales Corp. do?

Acquired Sales Corp. is currently transitioning from its previous focus on software and hardware to the cannabidiol (CBD) market. The company is exploring potential acquisitions of operating businesses involved in the manufacture and sale of CBD-infused products, including beverages, topicals, and other CBD-based consumer goods. AQSP aims to capitalize on the growing demand for CBD products and establish a presence in this rapidly expanding market through strategic acquisitions and product development.

What do analysts say about AQSP stock?

As of 2026-03-17, there is no available analyst coverage or consensus on Acquired Sales Corp. (AQSP) stock. This is likely due to the company's small size, OTC listing, and ongoing business transition. Investors should conduct their own independent research and consider the risks associated with investing in a company with limited analyst coverage. Key valuation metrics, such as price targets and earnings estimates, are not currently available.

What are the main risks for AQSP?

Acquired Sales Corp. faces several key risks, including intense competition in the CBD market, evolving regulatory landscape for CBD products, dependence on successful acquisitions to execute its business strategy, and its current lack of significant operations. The company's negative P/E ratio and profit margin highlight its current financial challenges. Additionally, as an OTC-listed stock, AQSP is subject to higher price volatility and liquidity risks compared to exchange-listed stocks. Investors should carefully consider these risks before investing.

Is AQSP a good investment right now?

Use the AI score and analyst targets on this page to evaluate Acquired Sales Corp. (AQSP). Our analysis considers fundamentals, technicals, and market sentiment to help you decide.

What is the MoonshotScore for AQSP?

The MoonshotScore is a proprietary 0-100 AI rating that evaluates Acquired Sales Corp. across multiple dimensions including financial health, growth trajectory, and risk factors.

Where can I find AQSP financial statements?

Acquired Sales Corp. financial data including revenue, earnings, and balance sheet metrics are available in the Financials tab on this page, sourced from institutional-grade data providers.

What do analysts say about AQSP?

Analyst consensus targets and ratings for Acquired Sales Corp. are shown in the analysis section. These are aggregated from major Wall Street firms and updated regularly.

How volatile is AQSP stock?

Check the beta and historical price range on this page to assess Acquired Sales Corp.'s volatility relative to the broader market.